Ilya V. Ulasov

Sechenov University — Russia

Biochemistry, Genetics and Molecular Biology · Life Sciences

40h-index8.3kcitations143works4.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(58), RNA Interference and Gene Delivery(49), CAR-T cell therapy research(33), Autophagy in Disease and Therapy(13), Glioma Diagnosis and Treatment(12)

Publications142 total

Combination of lactoferrin-based microparticles and carboanhydrase II inhibitor demonstrates enhanced inhibition effect on Ewing sarcoma cells
Nanomedicine Nanotechnology Biology and Medicine·2026
Targeting autophagy and metabolism for ewing sarcoma
Molecular Biology Reports·2025
The microenvironment of glioblastoma: in pursuit of universal multimodal immunotherapy
Acta Neurologica Belgica·2025
Microsatellite instability and PD-L1 expression in sarcomas: current evidence and clinical perspectives
Medical Oncology·2025
Enhancing the therapeutic effect on tumor cells through wireless optoelectronic stimulation
Journal of Neuro-Oncology·2025· 1 cited
Peri-Implantation Targeting Using Modified Adenoviral Vectors
Journal of Anatomy and Histopathology·2025Open Access
Assessment of a Structurally Modified Alternanthera Mosaic Plant Virus as a Delivery System for Sarcoma Cells
Viruses·2024Open Access
GBM Immunotherapy: Macrophage Impacts
Immunological Investigations·2024· 7 cited
Pharmacological Insights: Mitochondrial ROS Generation by FNC (Azvudine) in Dalton’s Lymphoma Cells Revealed by Super Resolution Imaging
Cell Biochemistry and Biophysics·2024· 13 cited
FNC (4′-azido-2′-deoxy-2′-fluoro(arbino)cytidine) as an Effective Therapeutic Agent for NHL: ROS Generation, Cell Cycle Arrest, and Mitochondrial-Mediated Apoptosis
Cell Biochemistry and Biophysics·2024· 13 cited
Mitochondrial-mediated apoptosis as a therapeutic target for FNC (2′-deoxy-2′-b-fluoro-4′-azidocytidine)-induced inhibition of Dalton’s lymphoma growth and proliferation
Discover Oncology·2024· 10 citedOpen Access
Idiopathic Pulmonary Fibrosis: Where do We Stand and How Far to Go?
Discovery Medicine·2024· 11 citedOpen Access
Advances of Genome Editing with CRISPR/Cas9 in Neurodegeneration: The Right Path towards Therapy
Biomedicines·2023· 18 citedOpen Access
Carbonic Anhydrase Inhibitors Induce Ferroptosis through Inhibition of AKT/FTH1 Signaling in Ewing Sarcoma Tumor Cells
Cancers·2023· 7 citedOpen Access
Metixene is an incomplete autophagy inducer in preclinical models of metastatic cancer and brain metastases
Journal of Clinical Investigation·2023· 17 citedOpen Access
Safety Assessment of a Nucleoside Analogue FNC (2’-deoxy-2’- β-fluoro-4’-azidocytidine ) in Balb/c Mice: Acute Toxicity Study
Asian Pacific Journal of Cancer Prevention·2023· 9 citedOpen Access
Autophagy in Cancer Progression and Therapeutics
International Journal of Molecular Sciences·2023· 2 citedOpen Access
Combination of conservative and surgical methods in the treatment of giant lymphedema of the scrotum: A case report
Frontiers in Surgery·2023· 10 citedOpen Access
Ewing sarcoma treatment: a gene therapy approach
Cancer Gene Therapy·2023· 14 citedOpen Access
The spectrum of cell death in sarcoma
Biomedicine & Pharmacotherapy·2023· 4 citedOpen Access
page 1 of 8Next →

Frequent Co-authors

Maciej S. Lesniak(34), Matthew A. Tyler(12), Adam M. Sonabend(11), Yu Han(11), David T. Curiel(8), Zeng B. Zhu(7), Ángel A. Rivera(6), Atique U. Ahmed(6), Bart Thaçi(6), Jawad Fares(5), Charles Cobbs(5), Minghui Wang(4), Derek A. Wainwright(4), Yu Han(4), Elena A. Rozhkova(3), Mahua Dey(3), Irina V. Balyasnikova(3), Karen S. Aboody(3), Maciej S. Lesniak(3), Sumon Nandi(3)